| Name | Number of Reports | Reference(s) | Data Source | |
|---|---|---|---|---|
| 1 | Aspirin | FAERS: 2 | US FAERS | |
| 2 | Clindamycin | FAERS: 2 | US FAERS | |
| 3 | Clopidogrel | FAERS: 2 | US FAERS | |
| 4 | Diclofenac | FAERS: 2 | US FAERS | |
| 5 | Nexium 24hr | FAERS: 2 | US FAERS | |
| 6 | Omeprazole | FAERS: 2 | US FAERS | |
| 7 | Rivaroxaban | FAERS: 2 | US FAERS | |
| 8 | Amlodipine | FAERS: 1 | US FAERS | |
| 9 | Ibandronic Acid | FAERS: 1 | US FAERS | |
| 10 | Imatinib Mesylate | FAERS: 1 | US FAERS | |
| 11 | Norgestrel | FAERS: 1 | US FAERS | |
| 12 | Venlafaxine Hydrochloride | FAERS: 1 | US FAERS | |
| 13 | carbidopa, levodopa drug combination | FAERS: 1 | US FAERS | |
| 14 | miglustat | FAERS: 1 | US FAERS | |
| 15 | Rabeprazole | Canada Vigilance: 1 | Canada Vigilance |
Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120295
Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.